Literature DB >> 9880529

Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase.

A Pellacani1, M T Chin, P Wiesel, M Ibanez, A Patel, S F Yet, C M Hsieh, J D Paulauskis, R Reeves, M E Lee, M A Perrella.   

Abstract

Nonhistone chromosomal proteins of the high mobility group (HMG) affect the transcriptional regulation of certain mammalian genes. For example, HMG-I(Y) controls cytokine-mediated promoters that require transcription factors, such as nuclear factor-kappaB, for maximal expression. Even though a great deal is known about how HMG-I(Y) facilitates expression of other genes, less is known about the regulation of HMG-I(Y) itself, especially in cells in primary culture. Therefore we investigated the effect of endotoxin and the cytokine interleukin-1beta on HMG-I(Y) expression in vascular smooth muscle cells. Induction of HMG-I(Y) peaked after 48 h of interleukin-1beta stimulation (6.2-fold) in cells in primary culture, and this increase in mRNA corresponded to an increase in HMG-I(Y) protein. Moreover, immunohistochemical staining revealed a dramatic increase in HMG-I(Y) protein expression in vascular smooth muscle cells after endotoxin stimulation in vivo. This increase in HMG-I(Y) expression (both in vitro and in vivo) mirrored an up-regulation of inducible nitric oxide synthase, a cytokine-responsive gene. The functional significance of this coinduction is underscored by our finding that HMG-I(Y) potentiated the response of inducible nitric oxide synthase to nuclear factor-kappaB transactivation. Taken together, these studies suggest that induction of HMG-I(Y), and subsequent transactivation of iNOS, may contribute to a reduction in vascular tone during endotoxemia and other systemic inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9880529     DOI: 10.1074/jbc.274.3.1525

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins.

Authors:  M Bustin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Non-NF-kappaB elements are required for full induction of the rat type II nitric oxide synthase in vascular smooth muscle cells.

Authors:  H Zhang; X Teng; C Snead; J D Catravas
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Poly(ADP-ribose) polymerase-1 and its cleavage products differentially modulate cellular protection through NF-kappaB-dependent signaling.

Authors:  Paola Castri; Yang-Ja Lee; Todd Ponzio; Dragan Maric; Maria Spatz; Joliet Bembry; John Hallenbeck
Journal:  Biochim Biophys Acta       Date:  2014-03

4.  Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.

Authors:  R Reeves; D D Edberg; Y Li
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 5.  The HMG I proteins: dynamic roles in gene activation, development, and tumorigenesis.

Authors:  F Liu; K Y Chau; P Arlotta; S J Ono
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  Frontline Science: Targeted expression of a dominant-negative high mobility group A1 transgene improves outcome in sepsis.

Authors:  Rebecca M Baron; Min-Young Kwon; Ana P Castano; Sailaja Ghanta; Dario F Riascos-Bernal; Silvia Lopez-Guzman; Alvaro Andres Macias; Bonna Ith; Scott L Schissel; James A Lederer; Raymond Reeves; Shaw-Fang Yet; Matthew D Layne; Xiaoli Liu; Mark A Perrella
Journal:  J Leukoc Biol       Date:  2018-07-05       Impact factor: 4.962

Review 7.  The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.

Authors:  Arindam Dhar; Mathew R Young; Nancy H Colburn
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

8.  The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.

Authors:  Makoto Osaki; Lujian Tan; Bob K Choy; Yasuhiro Yoshida; Kathryn S E Cheah; Philip E Auron; Mary B Goldring
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

9.  Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.

Authors:  Rebecca M Baron; Silvia Lopez-Guzman; Dario F Riascos; Alvaro A Macias; Matthew D Layne; Guiying Cheng; Cailin Harris; Su Wol Chung; Raymond Reeves; Ulrich H von Andrian; Mark A Perrella
Journal:  PLoS One       Date:  2010-05-14       Impact factor: 3.240

10.  High mobility group A1 protein mediates human nitric oxide synthase 2 gene expression.

Authors:  Rina Takamiya; Rebecca M Baron; Shaw-Fang Yet; Matthew D Layne; Mark A Perrella
Journal:  FEBS Lett       Date:  2008-02-13       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.